This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_OESOPHAGUS_EXALLC for full statistics.
Carcinoma in situ of oesophagus
CD2_INSITU_OESOPHAGUS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519361 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
41 |
4. Check minimum number of eventsNone |
41 |
5. Include endpointsNone |
41 |
6. Filter based on genotype QC (FinnGen only) |
41 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00
- Name in latin
- Carcinoma in situ coli
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of oesophagus
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of oesophagus
- Carcinoma in situ of oral cavity, oesophagus and stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 41 | 8 | 33 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 69.25 | 70.95 | 68.83 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
23
34
14.13
16.86
3.7
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
32
150
6.14
6.40
8.3
4.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
23
88
4.68
5.62
4.0
2.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
27
121
4.61
5.27
4.0
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
41
4.67
4.68
11.6
11.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
28
156
3.51
3.48
2.4
2.0
pmol/l
98.2
88.3
0.48
18
83
(40768804) Tissue Pathology biopsy report
24
126
3.18
3.22
3.7
2.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
13
49
3.42
2.96
5.7
4.5
%
31.0
29.3
—
7
31
(3022313) Gas panel - Capillary blood
8
21
4.47
2.62
5.6
3.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
31
205
3.10
2.52
7.2
4.4
mmol/l
7.1
6.8
0.30
31
195
(3020961) Endomysium IgA Ab [Titer] in Serum
5
8
6.92
2.44
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
9
30
3.55
2.32
4.0
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
24
145
2.58
2.23
11.0
4.8
g/l
34.2
34.8
0.23
24
140
(36660697) Celiac disease serology panel - Serum
7
20
4.00
2.16
1.9
1.2
—
—
—
0
0
(3020891) Body temperature
6
15
4.49
2.12
5.8
3.6
—
—
—
0
0
(3019225) pH of Specimen
10
39
3.07
2.10
3.2
5.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
19
106
2.48
2.05
3.1
3.5
mg/l
2932.6
84.7
0.46
13
70
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
6
16
4.20
2.01
3.2
1.4
ug/l
390.3
470.9
—
6
16
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
8
28
3.29
1.98
1.5
3.4
umol/l
7.3
11.5
—
8
22
(3022145) Colonoscopy Study observation
7
22
3.61
1.98
1.7
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
19
109
2.38
1.90
6.9
5.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
12
4.58
1.88
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
31
2.95
1.77
2.5
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
25
3.16
1.74
1.3
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
20
3.33
1.65
7.2
8.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
19
115
2.22
1.63
3.4
4.4
mg/mmol
2.1
11.7
1.68
13
77
(3002256) Pathology report gross observation
10
46
2.55
1.54
1.4
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
13
69
2.29
1.49
3.8
3.3
mmol/l
0.8
0.8
0.97
13
64
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
38
0.00
1.43
0.0
3.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
56
2.32
1.37
2.2
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
7
131
0.44
1.29
2.7
3.1
e6/l
19.4
73.2
—
7
101
(3000330) Specific gravity of Urine by Test strip
5
19
2.85
1.25
1.6
5.9
—
—
—
0
0
(4035726)
7
31
2.51
1.17
1.3
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
31
2.51
1.17
7.3
6.6
%
1.4
1.4
—
7
31
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
31
2.51
1.17
7.3
7.4
%
0.9
0.6
—
7
31
(3018095) Leukocytes [#/volume] in Urine
8
136
0.49
1.09
3.0
3.9
e6/l
185.2
22.8
—
8
102
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
34
286
2.10
0.99
5.0
4.1
mu/l
1.9
2.0
0.31
27
251
(36304419) Bacteria [Presence] in Urine
6
108
0.48
0.88
3.7
2.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
18
128
1.72
0.86
3.1
4.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
6
33
1.95
0.82
1.0
1.9
g/l
64.3
66.7
—
6
28
(3022217) INR in Platelet poor plasma by Coagulation assay
9
55
1.81
0.81
38.2
24.6
—
1.1
—
0
8
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
27
0.00
0.80
0.0
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
0
27
0.00
0.80
0.0
4.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
32
271
1.82
0.79
24.7
18.6
%
34.3
39.5
0.65
14
184
(3007853) Bacteria identified in Skin by Aerobe culture
7
41
1.85
0.74
2.7
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
36
323
1.94
0.65
28.8
17.4
mg/l
27.3
28.2
0.07
36
266
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
19
0.00
0.62
0.0
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
6
36
1.78
0.60
4.2
7.6
mmol/l
6.3
10.4
—
6
36
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
34
303
1.71
0.59
8.7
6.9
mmol/mol
43.4
41.1
0.63
29
283
(3000991) Gas panel - Venous blood
6
37
1.73
0.58
8.7
8.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
27
228
1.54
0.56
5.1
4.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
64
1.52
0.56
1.0
1.4
—
—
—
0
0
(3012544) pH of Venous blood
6
40
1.58
0.54
2.3
4.3
—
—
—
0
0
(3013512) EKG study
15
114
1.50
0.50
7.4
4.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
14
106
1.49
0.47
3.3
3.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
20
163
1.44
0.47
2.2
2.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
55
1.56
0.47
5.9
4.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5
32
1.64
0.44
1.6
1.8
nmol/l
415.2
344.6
—
5
27
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15
117
1.44
0.43
3.6
5.0
—
—
—
0
0
(4010399)
5
33
1.58
0.43
2.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
66
1.46
0.42
1.9
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
16
0.00
0.42
0.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
18
0.00
0.41
0.0
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5
75
0.62
0.40
2.0
3.3
mmol/l
2.5
2.5
—
5
63
(3011397) Hemoglobin [Presence] in Urine by Test strip
11
82
1.47
0.39
3.8
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
43
1.46
0.37
1.5
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
44
1.42
0.36
1.5
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
10
76
1.42
0.32
7.2
7.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
11
86
1.38
0.30
2.4
1.7
mmol/l
1.2
1.4
0.26
11
72
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
17
144
1.31
0.28
2.6
3.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
42
1.22
0.22
1.6
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
42
1.22
0.22
1.2
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
10
0.00
0.21
0.0
3.4
—
—
—
0
0
(4094501)
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
18
159
1.24
0.20
3.9
6.3
—
0.0
—
0
30
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
35
334
1.33
0.17
5.9
5.4
mmol/l
2.3
2.6
0.62
30
302
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
34
324
1.29
0.16
5.7
4.8
mmol/l
4.2
4.4
0.32
28
295
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
34
322
1.33
0.16
6.3
5.0
mmol/l
6.1
6.2
0.07
29
293
(3044889) 12 lead EKG panel
22
238
0.84
0.15
5.6
4.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7
79
0.86
0.08
2.1
4.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
9
98
0.90
0.07
2.4
4.4
—
7.4
—
0
17
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
18
172
1.08
0.03
4.3
4.5
%
18.8
21.4
—
7
84
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
31
312
0.97
0.00
5.0
4.3
mmol/l
1.3
1.3
0.15
25
283
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.4
—
197.6
—
0
7
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
7
0.00
0.00
0.0
4.0
—
8.5
—
0
7
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
7
69
1.02
0.00
2.6
3.0
ng/l
375.6
110.0
—
7
60
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
1.6
—
1.5
—
0
7
(3013290) Carbon dioxide [Partial pressure] in Blood
0
7
0.00
0.00
0.0
4.0
—
4.6
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
264.6
—
0
8
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
3.6
—
0
6
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
2.4
—
33.0
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
3.0
—
8.0
—
0
5
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
0.5
—
0
6
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
9
0.00
0.00
0.0
3.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
5.3
—
0
9
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
732.3
—
0
8
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
8
0.00
0.00
0.0
2.8
—
66.3
—
0
8
(3035637) Corticotropin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1002224) Polysomnography panel
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
33
324
1.09
0.00
5.8
4.7
mmol/l
1.3
1.4
0.64
27
293
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OESOPHAGUS – Carcinoma in situ of oesophagus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).